1 SmartCoin bet $61,200 on "Will Finland win the 2026 Eurovision Song Contest" and the result was "No".
According to PolyBeats monitoring, in the prediction market Polymarket, 1 smart dollar has been wagered on "Will Finland win the 2026 Eurovision Song Contest" as "No," with an average buying probability of 65.3% and the current "Yes" probability at 35.0%.
donaldinhotrumpito has wagered $61.2 thousand, with the top-relevant category in this market being Culture, with a net profit of $34.4 thousand. His win rate in this category, out of 23 settled trades, is 22/23 (96%), with 0 trades where the buy price was below $0.8 and the sell price was above $0.95.
The 2026 Eurovision Song Contest will be held in Vienna, Austria, with the two semi-finals scheduled for May 12 and May 14 and the grand final on May 16. Currently, Finland has the highest odds of winning among all participating countries. This year's Eurovision Song Contest has been impacted by controversy surrounding Israel's participation, with several countries confirming their non-participation, including Ireland, Spain, the Netherlands, Slovenia, and Iceland.
Finland will be represented this year by Linda Lampenius and Pete Parkkonen, performing the song "Liekinheitin" (Flamethrower). Various European media outlets and betting websites currently list Finland as a top contender for the championship, primarily due to "Liekinheitin" blending pop, rock, classical violin, and stage presence, with Linda Lampenius being an internationally renowned violinist and Pete Parkkonen being a Finnish pop singer.
Finland is not traditionally a powerhouse in the Eurovision Song Contest. According to Eurovisionworld statistics, since their debut in 1961, Finland has only won once in 2006 out of 58 participations.
Account:
0x7523cafcee7bcf2db9a79d80e0d79b88a9a54c4c.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GlaxoSmithKline endorses: anti-inflammatory biotech company Rezera (RZRA.US) plans to raise $200 millions through IPO, with a valuation of $254 millions
Rezera plans to raise $200 million in its IPO on Nasdaq, with an offering price between $11 and $13. GSK intends to subscribe for up to $25 million. The mid-point valuation is $254 million, and the company focuses on oral NLRP3 inhibitors.
BUZZ-3M India shares fall to 19-month low due to quarterly profit decline
Anthropic (ANT.US) to launch IPO roadshow next week, valuation may shrink from 1.5 trillion dollars to 1 trillion dollars! The AI capital feast faces a test.
After the AI sell-off, major investors are questioning whether Anthropic can go public at a $1.5 trillion valuation, or if it will be reduced to around $1 trillion. Fundraising may also decrease from $100 billion to $80 billion.
Hong Kong live music service provider Guitar Group applies for US IPO, aiming to raise $31 million
Guitar Group, a provider of music performance events, guitar-making workshops, and guitar repair services, submitted an application to the U.S. Securities and Exchange Commission (SEC) on Thursday, seeking to raise up to $31 million through an initial public offering (IPO).
Crypto prices
More
